更正：用于开发抗癌治疗药物的汞基制剂的物理化学表征及细胞毒性评估。
Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals.
作者信息
Kannan N, Shanmuga Sundar S, Balaji S, Amuthan Arul, Anil Kumar N V, Balasubramanian N
出版信息
PLoS One. 2018 Jun 26;13(6):e0200035. doi: 10.1371/journal.pone.0200035. eCollection 2018.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0195800.].
摘要
[本文更正文章DOI：10.1371/journal.pone.0195800。]
相似文献
1
Correction: Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals.更正：用于开发抗癌治疗药物的汞基制剂的物理化学表征及细胞毒性评估。
PLoS One. 2018 Jun 26;13(6):e0200035. doi: 10.1371/journal.pone.0200035. eCollection 2018.
2
Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals.汞基制剂的理化特性分析及细胞毒性评估，旨在开发抗癌治疗药物。
PLoS One. 2018 Apr 18;13(4):e0195800. doi: 10.1371/journal.pone.0195800. eCollection 2018.
3
Correction: Evaluation of porogen factors for the preparation of ion imprinted polymer monoliths used in mercury removal.更正：用于汞去除的离子印迹聚合物整体柱制备的致孔剂因素评估。
PLoS One. 2018 Nov 26;13(11):e0208242. doi: 10.1371/journal.pone.0208242. eCollection 2018.
4
Correction: Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047.更正：基于多胺的纳米载体Nano11047抗癌潜力的生化评估。
PLoS One. 2017 May 16;12(5):e0178102. doi: 10.1371/journal.pone.0178102. eCollection 2017.
5
Correction: Synthesis, characterization, quantum chemical calculations and anticancer activity of a Schiff base NNOO chelate ligand and Pd(II) complex.更正：席夫碱NNOO螯合配体与钯（II）配合物的合成、表征、量子化学计算及抗癌活性
PLoS One. 2021 Mar 25;16(3):e0249437. doi: 10.1371/journal.pone.0249437. eCollection 2021.
6
Correction: Properties of halogenated and sulfonated porphyrins relevant for the selection of photosensitizers in anticancer and antimicrobial therapies.
PLoS One. 2018 Jan 19;13(1):e0191777. doi: 10.1371/journal.pone.0191777. eCollection 2018.
7
Correction: Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation.更正：通过在纯品和药物制剂中操纵比率光谱同时定量氨氯地平和塞来昔布的紫外分光光度法的开发
PLoS One. 2019 Dec 30;14(12):e0227412. doi: 10.1371/journal.pone.0227412. eCollection 2019.
8
Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet.更正：泡腾漂浮型甲磺酸伊马替尼缓释片的处方及体外、体内评价
PLoS One. 2022 Sep 21;17(9):e0275144. doi: 10.1371/journal.pone.0275144. eCollection 2022.
9
Correction: Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome.更正：新型微粉化和超微粉化N-棕榈酰乙醇胺制剂在复杂性区域疼痛综合征胫骨骨折小鼠模型中的作用
PLoS One. 2018 Jul 25;13(7):e0201501. doi: 10.1371/journal.pone.0201501. eCollection 2018.
10
Correction: Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy.更正：揭示抗癌先导物与人血清白蛋白结合的分子和生理过程：对药物疗效的物理学洞察。
PLoS One. 2017 May 23;12(5):e0178660. doi: 10.1371/journal.pone.0178660. eCollection 2017.
本文引用的文献
1
Physiochemical characterization and cytotoxicity evaluation of mercury-based formulation for the development of anticancer therapeuticals.汞基制剂的理化特性分析及细胞毒性评估，旨在开发抗癌治疗药物。
PLoS One. 2018 Apr 18;13(4):e0195800. doi: 10.1371/journal.pone.0195800. eCollection 2018.
Zotero 插件